Skip to content

Interim phase 2 analysis shows zamto-cel activity in DLBCL
Dr. Lane discusses results of triplet combo in BPCDN
New therapies push UK registries into central role
FDA approves subcutaneous mosunetuzumab in relapsed or refractory follicular lymphoma
Dr. Gloria Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Guillermo Garcia-Manero, MD

Cellular Therapy

Guillermo Garcia-Manero, MD

Leukemia

Guillermo Garcia-Manero, MD

Lymphoma

Guillermo Garcia-Manero, MD

Multiple Myeloma

Guillermo Garcia-Manero, MD

Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 20, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Guillermo Garcia-Manero, MD

Guillermo Garcia-Manero, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
443 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Nirav shah

Cellular Therapy, Lymphoma, Aggressive B-Cell Lymphomas, Meetings / Conferences, 2025 Tandem Meetings, News

Interim phase 2 analysis shows zamto-cel activity in DLBCL

March 19, 2026

ASH 2025, Leukemia

Dr. Lane discusses results of triplet combo in BPCDN

March 18, 2026

SOHO UK, Leukemia, Acute Myeloid Leukemia, News

New therapies push UK registries into central role

March 18, 2026

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Cellular Therapy, Lymphoma, Indolent B-Cell Lymphomas, News

FDA approves subcutaneous mosunetuzumab in relapsed or refractory follicular

March 17, 2026

SOHO Insider podcast

SOHO UK, Cellular Therapy, Lymphoma, News, SOHO Insider Podcast

Dr. Gloria Iacoboni on improving CAR T-cell therapy outcomes

March 17, 2026

SOHO UK, Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Aggressive B-Cell Lymphomas, News

Q&A: Dr. Gohil on the multidisciplinary approach to HLH

March 16, 2026

Top Categories

Cellular Therapy

58

Leukemia

94

Lymphoma

100

Multiple Myeloma

82

Myelodysplastic Syndromes

31

Myeloproliferative Neoplasms

20

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Guillermo Garcia-Manero, MD

Cellular Therapy

Guillermo Garcia-Manero, MD

Leukemia

Guillermo Garcia-Manero, MD

Lymphoma

Guillermo Garcia-Manero, MD

Multiple Myeloma

Guillermo Garcia-Manero, MD

Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Nirav shah

Interim phase 2 analysis shows zamto-cel activity in DLBCL

Dr. Lane discusses results of triplet combo in BPCDN

New therapies push UK registries into central role

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.